Lewis JD - Search Results

1

Cancer risk in patients with inflammatory bowel disease.

Lewis JD, Deren JJ, Lichtenstein GR. Lewis JD, et al. Gastroenterol Clin North Am. 1999 Jun;28(2):459-77, x. doi: 10.1016/s0889-8553(05)70065-0. Gastroenterol Clin North Am. 1999. PMID: 10372277 Free article. Review.

2

Nutrition support in inflammatory bowel disease.

Lewis JD, Fisher RL. Lewis JD, et al. Med Clin North Am. 1994 Nov;78(6):1443-56. doi: 10.1016/s0025-7125(16)30110-9. Med Clin North Am. 1994. PMID: 7967919 Free article. Review.

3

Screening for colorectal cancer and other GI cancers.

Scotiniotis I, Lewis JD, Strom BL. Scotiniotis I, et al. Among authors: lewis jd. Curr Opin Oncol. 1999 Jul;11(4):305-11. doi: 10.1097/00001622-199907000-00011. Curr Opin Oncol. 1999. PMID: 10416884 Review.

4

Fatal hyperammonemia after orthotopic lung transplantation.

Lichtenstein GR, Yang YX, Nunes FA, Lewis JD, Tuchman M, Tino G, Kaiser LR, Palevsky HI, Kotloff RM, Furth EE, Bavaria JE, Stecker MM, Kaplan P, Berry GT. Lichtenstein GR, et al. Among authors: lewis jd. Ann Intern Med. 2000 Feb 15;132(4):283-7. doi: 10.7326/0003-4819-132-4-200002150-00006. Ann Intern Med. 2000. PMID: 10681283

5

Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma.

Lewis JD, Schwartz JS, Lichtenstein GR. Lewis JD, et al. Gastroenterology. 2000 Jun;118(6):1018-24. doi: 10.1016/s0016-5085(00)70353-2. Gastroenterology. 2000. PMID: 10833475 Free article.

6

Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?

Su CG, Stein RB, Lewis JD, Lichtenstein GR. Su CG, et al. Among authors: lewis jd. Dig Liver Dis. 2000 Aug-Sep;32(6):518-31. doi: 10.1016/s1590-8658(00)80010-9. Dig Liver Dis. 2000. PMID: 11057928 Free article. Review.

7

Dieulafoy's lesion of the small bowel causing massive gastrointestinal bleeding: two case reports and literature review.

Blecker D, Bansal M, Zimmerman RL, Fogt F, Lewis J, Stein R, Kochman ML. Blecker D, et al. Am J Gastroenterol. 2001 Mar;96(3):902-5. doi: 10.1111/j.1572-0241.2001.03641.x. Am J Gastroenterol. 2001. PMID: 11280574 Review.

8

Inflammatory bowel disease is not associated with an increased risk of lymphoma.

Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Lewis JD, et al. Gastroenterology. 2001 Nov;121(5):1080-7. doi: 10.1053/gast.2001.28703. Gastroenterology. 2001. PMID: 11677199

9

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.

Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD. Lewis JD, et al. Am J Gastroenterol. 2001 Dec;96(12):3323-8. doi: 10.1111/j.1572-0241.2001.05333.x. Am J Gastroenterol. 2001. PMID: 11774944

10

Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease.

Lewis JD, Brensinger C, Bilker WB, Strom BL. Lewis JD, et al. Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):211-8. doi: 10.1002/pds.698. Pharmacoepidemiol Drug Saf. 2002. PMID: 12051120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,170 results

Search Page